Plant adaptive agents: promising therapeutic molecules in the treatment of post-viral fatigue

Abstract

In recent years, the spread of the coronavirus disease 2019 (COVID-19) in China has been effectively controlled by implementing national prevention and control measures. However, a large number of recovered patients are plagued by fatigue, whether acute or chronic, and other fatigue-related syndromes that severely affect their quality of life. Post-viral fatigue syndrome (PVFS) is a widespread chronic neurological disease with no definite etiological factor(s), definitive diagnostic test, or approved pharmacological treatment, therapy, or cure. In this study, we performed a bibliometric analysis and the results suggested that neuroinflammation played a role in the development of PVFS. Therefore, we briefly analyzed the mechanisms underlying the development of neuroinflammation in patients with COVID-19. To identify effective drugs to alleviate PVSF, we summarized four traditional herbal phytoadaptations and discussed their molecular mechanisms in improving neurological fatigue. Our study showed that ginseng, Acanthopanax, Rhodiola, and Schisandra played beneficial roles in alleviating PVSF.

Keywords

Adaption / COVID-19 / Fatigue / Long COVID / Pody-viral fatigue syndrome / Traditional Chinese medicine

References

[[1]] Silva-Costa A, Griep RH, Rotenberg L. Percepção de risco de adoecimento por COVID-19 e depressão, ansiedade e estresse entre trabalhadores de unidades de saúde [Perceived risk from COVID-19 and depression, anxiety, and stress among workers in healthcare units]. Cad Saude Publica 2022;38(3):e00198321.

[[2]] Lou M, Yuan D, Liao S, et al. Potential mechanisms of cerebrovascular diseases in COVID-19 patients. J Neurovirol 2021;27(1):35-51.

[[3]] Ferraro F, Calafiore D, Dambruoso F, et al. COVID-19 related fatigue: which role for rehabilitation in post-COVID-19 patients? A case series. J Med Virol 2021;93(4):1896-1899.

[[4]] Chudzik M, Burzyńska M, Kapusta J. Use of 1-MNA to improve exercise tolerance and fatigue in patients after COVID-19. Nutrients 2022;14(15):3004.

[[5]] Hotchin NA, Read R, Smith DG, et al. Active Epstein- Barr virus infection in post-viral fatigue syndrome. J Infect 1989;18(2):143-150.

[[6]] Cunningham L, Bowles NE, Archard LC. Persistent virus infection of muscle in postviral fatigue syndrome. Br Med Bull 1991;47(4):852-871.

[[7]] Wirth KJ, Scheibenbogen C, Paul F. Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Transl Med 2022;20(1):25.

[[8]] Courtney R. Improvement rates in adolescent patients with chronic fatigue syndrome after receiving cognitive behavioural therapy. Eur J Pediatr 2014;173(5):691.

[[9]] Lyu M, Fan G, Xiao G, et al. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B 2021;11(11):3337-3363.

[[10]] Quan FS, Compans RW, Cho YK, et al. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine 2007;25(2):272-282.

[[11]] Harrell CR, Markovic BS, Fellabaum C, et al. Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed Pharmacother 2019;109:2318-2326.

[[12]] Burstein HJ, Curigliano G, Thürlimann B, et al.; Panelists of the St Gallen Consensus Conference. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol 2021;32(10):1216-1235.

[[13]] Wang M, Pan W, Xu Y, et al. Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res 2022;15:3083-3094.

[[14]] Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969;9:419-430.

[[15]] Kim DH. Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res 2012;36(1):1-15.

[[16]] Panossian AG, Efferth T, Shikov AN, et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med Res Rev 2021;41(1):630-703.

[[17]] Ginseng. In: Drugs and Lactation Database (LactMed). Bethesda (MD): National Library of Medicine (US); 2021.

[[18]] Bleakney TL. Deconstructing an adaptogen: Eleutherococcus senticosus. Holist Nurs Pract 2008;22(4):220-224.

[[19]] Ishaque S, Shamseer L, Bukutu C, et al. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med 2012;12:70.

[[20]] Rybnikář M, Šmejkal K, Žemlička M. Schisandra chinensis and its phytotherapeutical applications. Schisandra čínská a její využitíve fytoterapii. Ceska Slov Farm 2019;68(3):95-118.

[[21]] Song WJ, Hui CKM, Hull JH, et al. Confronting COVID-19- associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med 2021;9(5):533-544.

[[22]] Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Síndrome post-COVID-19: epidemiología, criterios diagnósticos y mecanismos patogénicos implicados. Rev Neurol 2021;72(11):384-396.

[[23]] Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses 2021;146:110469.

[[24]] Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit 2021;27:e931447.

[[25]] Carfì A, Bernabei R, Landi F, et al. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324(6):603-605.

[[26]] Adil MT, Rahman R, Whitelaw D, et al. SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J 2021;97(1144):110-116.

[[27]] Mitchell W. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev 2001;7(3):211-216.

[[28]] Forton DM, Taylor-Robinson SD, Thomas HC. Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2006;18(4):333-338.

[[29]] Nagel MA, Gilden D. Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol 2014;27(3):356-360.

[[30]] Wouk J, Rechenchoski DZ, Rodrigues BCD, et al. Viral infections and their relationship to neurological disorders. Arch Virol 2021;166(3):733-753.

[[31]] Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence 2021;12(1):2670-2702.

[[32]] Magro G. SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc. Cytokine X 2020;2(2):100029.

[[33]] Daniels BP, Holman DW, Cruz-Orengo L, et al. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. mBio 2014;5(5):e01476-e01414.

[[34]] Fernández-Castañeda A, Lu P, Geraghty AC, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 2022;185(14):2452-2468.e16.

[[35]] Normandin E, Holroyd KB, Collens SI, et al. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients. J Neurol Sci 2021;430:120023.

[[36]] McKlveen JM, Morano RL, Fitzgerald M, et al. Chronic stress increases prefrontal inhibition: a mechanism for stress-induced prefrontal dysfunction. Biol Psychiatry 2016;80(10):754-764.

[[37]] Garber C, Vasek MJ, Vollmer LL, et al. Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1. Nat Immunol 2018;19(2):151-161.

[[38]] Rhea EM, Logsdon AF, Hansen KM, et al. The S1 protein of SARSCoV- 2 crosses the blood-brain barrier in mice. Nat Neurosci 2021;24(3):368-378.

[[39]] Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. The SARSCoV- 2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier. Neurobiol Dis 2020;146:105131.

[[40]] Qian Y, Lei T, Patel PS, et al. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin. J Virol 2021;95(23):e0139621.

[[41]] Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol 2022;76:102608.

[[42]] Bisogno T, Di Marzo V. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol Disord Drug Targets 2010;9(5):564-573.

[[43]] Im DS. Pro-resolving effect of ginsenosides as an anti-inflammatory mechanism of panax ginseng. Biomolecules 2020;10(3):444.

[[44]] Wang C, Lou Y, Xu J, et al. Endoplasmic reticulum stress and NF-[Formula: see text]B pathway in salidroside mediated neuroprotection: potential of salidroside in neurodegenerative diseases. Am J Chin Med 2017;45(7):1459-1475.

[[45]] Zhang M, Xu L, Yang H. Schisandra chinensis fructus and its active ingredients as promising resources for the treatment of neurological diseases. Int J Mol Sci 2018;19(7):1970.

[[46]] Li XJ, Tang SQ, Huang H, et al. Acanthopanax henryi: review of botany, phytochemistry and pharmacology. Molecules 2021;26(8):2215.

[[47]] Alexander J, Tinkov A, Strand TA, et al. Early nutritional interventions with zinc, selenium and vitamin D for raising anti-viral resistance against progressive COVID-19. Nutrients 2020;12(8):2358.

[[48]] Kim DH, Kim DW, Jung BH, et al. Ginsenoside Rb2 suppresses the glutamate-mediated oxidative stress and neuronal cell death in HT22 cells. J Ginseng Res 2019;43(2):326-334.

[[49]] Li Y, Cai M, Mao GX, et al. Preclinical evidence and possible mechanisms of Rhodiola rosea L. and its components for ischemic stroke: a systematic review and meta-analysis. Front Pharmacol 2021;12:736198.

[[50]] Li X, Ye X, Li X, et al. Salidroside protects against MPP(+)- induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Res 2011;1382:9-18.

[[51]] Liu CJ, Zhang SQ, Zhang JS, et al.Chemical composition and antioxidant activity of essential oil from berries of Schisandra chinensis (Turcz.) Baill. Nat Prod Res 2012;26(23):2199-2203.

[[52]] Kamphuis W, Kooijman L, Orre M, et al. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer’s disease. Glia 2015;63(6):1036-1056.

[[53]] Panossian A. Understanding adaptogenic activity: specificity of the pharmacological action of adaptogens and other phytochemicals. Ann N Y Acad Sci 2017;1401(1):49-64.

[[54]] Liao LY, He YF, Li L, et al. A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chin Med 2018;13:57.

[[55]] Jin Y, Cui R, Zhao L, et al. Mechanisms of Panax ginseng action as an antidepressant. Cell Prolif 2019;52(6):e12696.

[[56]] Luo C, Xu X, Wei X, et al. Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms. Pharmacol Res 2019;148:104409.

[[57]] Lopresti AL, Smith SJ, Drummond PD. Modulation of the hypothalamic- pituitary-adrenal (HPA) axis by plants and phytonutrients: a systematic review of human trials. Nutr Neurosci 2022;25(8):1704-1730.

[[58]] McEwen BJ. The influence of herbal medicine on platelet function and coagulation: a narrative review. Semin Thromb Hemost 2015;41(3):300-314.

[[59]] Huang X, Li N, Pu Y, et al. Neuroprotective effects of ginseng phytochemicals: recent perspectives. Molecules 2019;24(16):2939.

[[60]] Leem KH, Kim SA, Park HJ. Antimania-like effect of panax ginseng regulating the glutamatergic neurotransmission in REMsleep deprivation rats. Biomed Res Int 2020;3636874.

[[61]] Karmazyn M, Gan XT. Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension. Mol Cell Biochem 2021;476(1):333-347.

[[62]] Nah SY. Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors. Front Physiol 2014;5:98.

[[63]] Friedl R, Moeslinger T, Kopp B, et al. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br J Pharmacol 2001;134(8):1663-1670.

[[64]] Kennedy DO, Scholey AB, Wesnes KA. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav 2002;75(5):739-751.

[[65]] Zhang XY. Pharmacodynamics function of athletic fatigue relief health food. AJFST 2016;10(2):149-152.

[[66]] Shin IS, Kim DH, Jang EY, et al. Anti-fatigue properties of cultivated wild ginseng distilled extract and its active component panaxydol in rats. J Pharmacopuncture 2019;22(2):68-74.

[[67]] Barton DL, Liu H, Dakhil SR, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 2013;105(16):1230-1238.

[[68]] Yennurajalingam S, Reddy A, Tannir NM, et al. High-dose asian ginseng (Panax Ginseng) for cancer-related fatigue: a preliminary report. Integr Cancer Ther 2015;14(5):419-427.

[[69]] Ueda H, Yamazaki M. Anti-inflammatory and anti-allergic actions by oral administration of a perilla leaf extract in mice. Biosci Biotechnol Biochem 2001;65(7):1673-1675.

[[70]] Lau KM, Yue GG, Chan YY, et al. A review on the immunomodulatory activity of Acanthopanax senticosus and its active components. Chin Med 2019;14:25.

[[71]] Deyama T, Nishibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin 2001;22(12):1057-1070.

[[72]] Huang LZ, Huang BK, Ye Q, et al. Bioactivity-guided fractionation for anti-fatigue property of Acanthopanax senticosus. J Ethnopharmacol 2011;133(1):213-219.

[[73]] Guan PS, Li ZX, Liao YM. Clinical study on the improvement of postoperative fatigue syndrome in patients with gastrointestinal tumor by Acanthopanax injection. Int Med Health Guidance News 2008;28(16):96-99.

[[74]] Ji XD, Wang QS. Clinical study on the treatment of chronic fatigue syndrome by acupancture point stimulation associated with CIWUJIA capsules. Proceedings of the 12th National Academic Conference on Integrative Psychiatry. 2013;84-86.

[[75]] Zhang X, Zhu W. Image Effect Observation of Acanthopanax senticosus on Antifatigue Activity after Exercise. Scanning 2022;7588680.

[[76]] Sellami M, Slimeni O, Pokrywka A, et al. Herbal medicine for sports: a review. J Int Soc Sports Nutr 2018;15:14.

[[77]] Zakharenko AM, Razgonova MP, Pikula KS, et al. Simultaneous Determination of 78 Compounds of Rhodiola rosea Extract by Supercritical CO2-Extraction and HPLC-ESI-MS/MS Spectrometry. Biochem Res Int 2021;9957490.

[[78]] Crosby MB, Svenson JL, Zhang J, et al. Peroxisome proliferation- activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther 2005;312(1):69-76.

[[79]] Li Y, Pham V, Bui M, et al. Rhodiola rosea L.:an herb with antistress, anti-aging, and immunostimulating properties for cancer chemoprevention. Curr Pharmacol Rep 2017;3(6):384-395.

[[80]] Shevtsov VA, Zholus BI, Shervarly VI, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003;10(2-3):95-105.

[[81]] Chen LJ, Cai DL, Wang Y, et al. Anti-fatigue Effect of Compound Salidroside Capsule. Occup and Health. 2011;27(11): 1214-1215.

[[82]] Song YH, Sun XW, Meng CH. Effect of hongjingtian decoction on serum MDA, SOD, NGF, MBP and BFGF levels of exercise-induced fatigue athletes. Chin J Biochem Pharm. 2015;35(8):119-121.

[[83]] Spasov AA, Wikman GK, Mandrikov VB, et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000;7(2):85-89.

[[84]] Li Z, He X, Liu F, et al. A review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: properties, functions and applications. Carbohydr Polym 2018;184:178-190.

[[85]] Yang K, Qiu J, Huang Z, et al. A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils. J Ethnopharmacol 2022;284:114759.

[[86]] Han W, Cong L, Shu J, et al. Optimal extraction process and antifatigue of mixed extract of schisandra chinensis and epimedium sagittatum. J Beihua Univ (Natural Science) 2017.

[[87]] Ye BH, Lee SJ, Choi YW, et al. Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability. Hypertens Res 2015;38(3):169-177.

[[88]] Jang Y, Lee JH, Lee MJ, et al. Schisandra extract and ascorbic acid synergistically enhance cognition in mice through modulation of mitochondrial respiration. Nutrients 2020;12(4):897.

[[89]] Bao C, Sun Y, Wang F, et al. Experimental study on the effect of Schisandra chinensis extract on relieving physical fatigue. CIATCM 2012;29(4):145-147.

[[90]] Su D, Luo J, Ge J, et al. Raw and wine processed schisandra chinensis regulate NREM-sleep and alleviate cardiovascular dysfunction associated with insomnia by modulating HPA axis [published online ahead of print, 2021 Dec 15]. Planta Med 2021;88(14):1311-1324.

[[91]] Zhang D, Hu S, Li W, et al. Schisandra A ameliorates cigarette smoke extract and lipopolysaccharide-induced oxidative stress in lung epithelial cells. J Thorac Dis 2020;12(3):394-402.

RIGHTS & PERMISSIONS

2023 Acupuncture and Herbal Medicine